Microdialysis in central nervous system disorders and their treatment

David J. McAdoo, Ping Wu

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Central nervous system (CNS) insults elevate endogenous toxins and alter levels of indicators of metabolic disorder. These contribute to neurotrauma, neurodegenerative diseases and chronic pain and are possible targets for pharmaceutical treatment. Microdialysis samples substances in the extracellular space for chemical analysis. It has demonstrated that toxic levels of glutamate are released and that toxic levels of the reactive species O2 -, H2O2, HO· NO and HOONO are generated upon CNS injury. Agent administration by microdialysis can also help elucidate mechanisms of damage and protection, and to identify targets for clinical application. Microdialysis sampling indicates that circuits descending from the brain to the spinal cord transmit and modulate pain signals by releasing neurotransmitter amines and amino acids. Efforts are under way to develop microdialysis into a technique for intensive care monitoring and predicting outcomes of brain insults. Finally, microdialysis sampling has demonstrated in vivo elevation of glial cell line-derived neurotrophic factor following grafting of primed fetal human neural stem cells into brain-injured rats, the first in vivo demonstration of the release of a neurotrophic factor by grafted stem cells. This increased release correlated with significantly improved spatial learning and memory.

Original languageEnglish (US)
Pages (from-to)282-296
Number of pages15
JournalPharmacology Biochemistry and Behavior
Volume90
Issue number2
DOIs
StatePublished - Aug 2008

Fingerprint

Central Nervous System Diseases
Microdialysis
Neurology
Brain
Poisons
Stem cells
Central Nervous System
Neurodegenerative diseases
Sampling
Nervous System Trauma
Glial Cell Line-Derived Neurotrophic Factor
Therapeutics
Neural Stem Cells
Nerve Growth Factors
Extracellular Space
Critical Care
Chronic Pain
Neurodegenerative Diseases
Amines
Neurotransmitter Agents

Keywords

  • Clinical application
  • Descending control
  • Excitotoxicity
  • Glutamate
  • Hydrogen peroxide
  • Hydroxyl radical
  • Microdialysis
  • Pain
  • Spinal cord injury
  • Stem cells
  • Superoxide
  • Traumatic brain injury

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Microdialysis in central nervous system disorders and their treatment. / McAdoo, David J.; Wu, Ping.

In: Pharmacology Biochemistry and Behavior, Vol. 90, No. 2, 08.2008, p. 282-296.

Research output: Contribution to journalArticle

@article{64d0c4edafa94651be2e32273e7b55e8,
title = "Microdialysis in central nervous system disorders and their treatment",
abstract = "Central nervous system (CNS) insults elevate endogenous toxins and alter levels of indicators of metabolic disorder. These contribute to neurotrauma, neurodegenerative diseases and chronic pain and are possible targets for pharmaceutical treatment. Microdialysis samples substances in the extracellular space for chemical analysis. It has demonstrated that toxic levels of glutamate are released and that toxic levels of the reactive species O2 -, H2O2, HO· NO and HOONO are generated upon CNS injury. Agent administration by microdialysis can also help elucidate mechanisms of damage and protection, and to identify targets for clinical application. Microdialysis sampling indicates that circuits descending from the brain to the spinal cord transmit and modulate pain signals by releasing neurotransmitter amines and amino acids. Efforts are under way to develop microdialysis into a technique for intensive care monitoring and predicting outcomes of brain insults. Finally, microdialysis sampling has demonstrated in vivo elevation of glial cell line-derived neurotrophic factor following grafting of primed fetal human neural stem cells into brain-injured rats, the first in vivo demonstration of the release of a neurotrophic factor by grafted stem cells. This increased release correlated with significantly improved spatial learning and memory.",
keywords = "Clinical application, Descending control, Excitotoxicity, Glutamate, Hydrogen peroxide, Hydroxyl radical, Microdialysis, Pain, Spinal cord injury, Stem cells, Superoxide, Traumatic brain injury",
author = "McAdoo, {David J.} and Ping Wu",
year = "2008",
month = "8",
doi = "10.1016/j.pbb.2008.03.001",
language = "English (US)",
volume = "90",
pages = "282--296",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Microdialysis in central nervous system disorders and their treatment

AU - McAdoo, David J.

AU - Wu, Ping

PY - 2008/8

Y1 - 2008/8

N2 - Central nervous system (CNS) insults elevate endogenous toxins and alter levels of indicators of metabolic disorder. These contribute to neurotrauma, neurodegenerative diseases and chronic pain and are possible targets for pharmaceutical treatment. Microdialysis samples substances in the extracellular space for chemical analysis. It has demonstrated that toxic levels of glutamate are released and that toxic levels of the reactive species O2 -, H2O2, HO· NO and HOONO are generated upon CNS injury. Agent administration by microdialysis can also help elucidate mechanisms of damage and protection, and to identify targets for clinical application. Microdialysis sampling indicates that circuits descending from the brain to the spinal cord transmit and modulate pain signals by releasing neurotransmitter amines and amino acids. Efforts are under way to develop microdialysis into a technique for intensive care monitoring and predicting outcomes of brain insults. Finally, microdialysis sampling has demonstrated in vivo elevation of glial cell line-derived neurotrophic factor following grafting of primed fetal human neural stem cells into brain-injured rats, the first in vivo demonstration of the release of a neurotrophic factor by grafted stem cells. This increased release correlated with significantly improved spatial learning and memory.

AB - Central nervous system (CNS) insults elevate endogenous toxins and alter levels of indicators of metabolic disorder. These contribute to neurotrauma, neurodegenerative diseases and chronic pain and are possible targets for pharmaceutical treatment. Microdialysis samples substances in the extracellular space for chemical analysis. It has demonstrated that toxic levels of glutamate are released and that toxic levels of the reactive species O2 -, H2O2, HO· NO and HOONO are generated upon CNS injury. Agent administration by microdialysis can also help elucidate mechanisms of damage and protection, and to identify targets for clinical application. Microdialysis sampling indicates that circuits descending from the brain to the spinal cord transmit and modulate pain signals by releasing neurotransmitter amines and amino acids. Efforts are under way to develop microdialysis into a technique for intensive care monitoring and predicting outcomes of brain insults. Finally, microdialysis sampling has demonstrated in vivo elevation of glial cell line-derived neurotrophic factor following grafting of primed fetal human neural stem cells into brain-injured rats, the first in vivo demonstration of the release of a neurotrophic factor by grafted stem cells. This increased release correlated with significantly improved spatial learning and memory.

KW - Clinical application

KW - Descending control

KW - Excitotoxicity

KW - Glutamate

KW - Hydrogen peroxide

KW - Hydroxyl radical

KW - Microdialysis

KW - Pain

KW - Spinal cord injury

KW - Stem cells

KW - Superoxide

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=44649170338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649170338&partnerID=8YFLogxK

U2 - 10.1016/j.pbb.2008.03.001

DO - 10.1016/j.pbb.2008.03.001

M3 - Article

VL - 90

SP - 282

EP - 296

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 2

ER -